San Francisco, CA, United States of America

Freeman Lan

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Freeman Lan: Innovator in Nucleic Acid Sequencing Technologies

Introduction

Freeman Lan is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of nucleic acid sequencing. With a total of 4 patents to his name, Lan has been at the forefront of developing innovative methods that enhance the efficiency and accuracy of genetic analysis.

Latest Patents

One of Lan's latest patents focuses on the sequencing of nucleic acids via barcoding in discrete entities. This patent introduces microfluidic methods for barcoding nucleic acid target molecules, which can be analyzed through various nucleic acid sequencing techniques. The methods provided facilitate high-throughput sequencing of nucleic acid target molecules, as well as genomic, transcriptomic, and proteomic analysis at the single-cell and single-virus levels. Additionally, the patent outlines systems and devices designed to implement these advanced methods effectively.

Career Highlights

Freeman Lan is affiliated with the University of California, where he continues to push the boundaries of research in molecular biology and genetics. His work has garnered attention for its potential applications in personalized medicine and biotechnology.

Collaborations

Lan collaborates with notable colleagues, including Adam R Abate and John R Haliburton, who contribute to the innovative research environment at the University of California.

Conclusion

Freeman Lan's work in nucleic acid sequencing technologies exemplifies the impact of innovation in the scientific community. His patents not only advance the field but also pave the way for future breakthroughs in genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…